Abstract PO2-06-11: A Phase II Randomized Trial of Gemcitabine Plus Cisplatin(gp) Vs Gemcitabine Plus Carboplatin (GC) As the First-Line Treatment for Patients with Metastatic Triple-Negative Breast Cancer
Cancer Research（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要